Neptune Pet. (NEPTUNE)

FairStock Score: 47/100 — MIXED

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Outstanding ROCE of 62.28% indicates highly efficient capital deployment
• Sales growth of 19.29% shows expanding business momentum
• Promoter holding of 69.33% ensures strong alignment with minority shareholders
• Piotroski F-Score of 7/9 points to solid financial fundamentals
• PEG of 1.18 suggests valuation is broadly fair for the growth rate

Concerns

• Profit growth of 12.88% lags sales growth of 19.29%, implying margin compression
• Zero dividend yield even with high ROCE raises questions about cash allocation
• Latest quarter net profit margin is thin at ~3.7%, reflecting low pricing power
• Missing book value, ROE, and debt/equity data limits a thorough value assessment
• Petrochemical cyclicality makes earnings vulnerable to commodity price swings

AI Analysis

Neptune Pet. presents a curious case. A petrochemical player earning a remarkable 62% ROCE, trading at a P/E of 18.96 with a PEG of 1.18. At first glance, that suggests efficient capital use. But I always ask: can this be sustained? The petrochemical industry is cyclical, and commodity businesses seldom build durable moats. Sales are growing at 19%, yet profit trails at under 13% - a telltale sign that rising input costs or competition are squeezing margins. The latest quarter's net profit of ₹15 Cr on ₹407 Cr sales is a thin 3.7% margin. That's not a franchise with pricing power; it's a price-taker. The promoter holding of 69% is reassuring - their interests align with mine. But zero dividend? A company with this return profile should be generating cash; if they can't pay me a token, I want to know where the cash flows. The Piotroski score of 7 suggests solid fundamentals, but I'm worried about the missing data - no book value, no ROE, no debt-to-equity. I cannot evaluate financial strength in a vacuum. At ₹209, I'm paying 19 times earnings for a cyclical with moderate growth. That's not a margin of safety. If the cycle turns, this stock could get punished. I'd wait for a cheaper price or evidence of widening margins. For now, it's a good business perhaps, but not a good investment at this price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer